Real-Time Beneficiary Drug Cost Bill
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jun 21, 2019)
Real-Time Beneficiary Drug Cost Bill
This bill provides statutory authority for certain provisions of the Centers for Medicare & Medicaid Services rule titled "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses," published on May 23, 2019. The rule requires, in part, Medicare prescription drug plan sponsors to implement an electronic, real-time benefit tool that is capable of integrating with at least one prescriber's electronic prescribing system or electronic health record. The tool must provide prescribers with patient-specific, real-time formulary and benefit information, including information regarding cost-sharing, formulary alternatives, and utilization management requirements. The rule takes effect January 1, 2021.
What just happenedJun 24, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJun 21, 2019
- Jun 24, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 21, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jun 21, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jun 21, 2019IntroReferralIntro-H
Introduced in House
- Jun 21, 2019IntroReferral1000
Introduced in House